Number of the records: 1  

Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors

  1. 1.
    0542632 - FGÚ 2022 RIV NL eng J - Journal Article
    Kolcheva, Marharyta - Kortus, Š. - Hrčka Krausová, B. - Baráčková, P. - Misiachna, A. - Danačíková, Šárka - Kaniaková, M. - Hemelíková, K. - Hotovec, M. - Řeháková, K. - Horák, M.
    Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors.
    Neuropharmacology. Roč. 189, 15 May (2021), č. článku 108528. ISSN 0028-3908. E-ISSN 1873-7064
    R&D Projects: GA ČR(CZ) GA20-12420S
    Institutional support: RVO:67985823
    Keywords : electrophysiology * glutamate receptor * hippocampal neuron * ion channel * memantine * membrane domain
    OECD category: Neurosciences (including psychophysiology
    Impact factor: 5.273, year: 2021
    Method of publishing: Limited access
    https://doi.org/10.1016/j.neuropharm.2021.108528

    N-methyl-d-aspartate receptors (NMDARs) play an essential role in regulating glutamatergic neurotransmission. Recently, pathogenic missense mutations were identified in genes encoding NMDAR subunits, however, their effect on NMDAR activity is often poorly understood. Here, we examined whether three previously identified pathogenic mutations (M641I, A645S, and Y647S) in the M3 domain of the GluN1 subunit affect the receptor's surface delivery, agonist sensitivity, Mg2+ block, and/or inhibition by the FDA-approved NMDAR blocker memantine. When expressed in HEK293 cells, we found reduced surface expression of GluN1-M641I/GluN2A, GluN1-Y647S/GluN2A, and GluN1-Y647S/GluN2B receptors, other mutation-bearing NMDAR combinations, including GluN1/GluN3A receptors, were expressed at normal surface levels. When expressed in rat hippocampal neurons, we consistently found reduced surface expression of the GluN1-M641I and GluN1-Y647S subunits when compared with wild-type GluN1 subunit. At the functional level, we found that GluN1-M641I/GluN2 and GluN1-A645S/GluN2 receptors expressed in HEK293 cells have wild-type EC50 values for both glutamate and glycine, in contrast, GluN1-Y647S/GluN2 receptors do not produce glutamate-induced currents. In the presence of a physiological concentration of Mg2+, we found that GluN1-M641I/GluN2 receptors have a lower memantine IC50 and slower offset kinetics, whereas GluN1-A645S/GluN2 receptors have a higher memantine IC50 and faster offset kinetics when compared to wild-type receptors. Finally, we found that memantine was the most neuroprotective in hippocampal neurons expressing GluN1-M641I subunits, followed by neurons expressing wild-type GluN1 and then GluN1-A645S subunits in an NMDA-induced excitotoxicity assay. These results indicate that specific pathogenic mutations in the M3 domain of the GluN1 subunit differentially affect the trafficking and functional properties of NMDARs.
    Permanent Link: http://hdl.handle.net/11104/0320020

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.